PENWEST PHARMACEUTICALS CO 4
4 · PENWEST PHARMACEUTICALS CO · Filed Mar 9, 2009
Insider Transaction Report
Form 4
Hawi Amale
SVP, Pharmaceutical Dev.
Transactions
- Award
Stock Option Right-to-Buy
2009-03-05+65,000→ 65,000 totalExercise: $1.56From: 2013-03-05Exp: 2019-03-05→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The options vest in four equal annual installments with the first installment vesting on 03/05/2010.